Stocks · News reference
Cosmos Health's Cana Laboratories Subsidiary Achieves Over $20M In Revenue
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that the contract manufacturing ("CMO") pipeline
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M
Cosmos Health Announces Engagement Of Prime Ledger To Structure Tokenized Financing Backed By CCX0722 Weight Management Hydrogel IP, With No Common Stock Issuance; Targets Initial Structuring Completion In Q4 2026